Hypertension and Vascular Disorders

Hypertension and Vascular Disorders

  • Pathophysiology and Risk Factors
  • Hypertension and Target Organ Damage
  • Vascular Disorders and Endothelial Dysfunction
  • Resistant Hypertension and Secondary Hypertension
  • Hypertension in Special Populations
     

Hypertension, or high blood pressure, is a widespread vascular disorder that significantly increases the risk of heart disease, stroke, and kidney failure. It results from a complex interplay of genetic, environmental, and lifestyle factors, which lead to increased vascular resistance and a greater workload on the heart. Over time, persistent hypertension causes damage to the arterial walls, promoting the development of atherosclerosis and weakening the heart muscle. This damage impairs the ability of the arteries to stretch and contract properly, which in turn reduces the efficiency of blood flow. Additionally, hypertension is often associated with other vascular disorders, such as peripheral artery disease, aneurysms, and vasculitis, which further hinder blood flow and reduce the delivery of oxygen to tissues. Managing hypertension involves both lifestyle interventions and pharmacological treatments. Lifestyle changes, including a healthy diet, regular exercise, weight management, and reduced sodium intake, are essential for controlling blood pressure. Pharmacological treatments, such as ACE inhibitors, beta-blockers, calcium channel blockers, and diuretics, are commonly used to help lower blood pressure and prevent complications. Ongoing research is focused on better understanding the underlying mechanisms of hypertension, particularly the role of endothelial dysfunction, the renin-angiotensin system, and inflammation. Innovations in treatment could provide better management of hypertension and its associated risks, helping to reduce the long-term consequences of this condition. As research continues, there is hope for more advanced, individualized therapies that will improve patient outcomes, reduce complications, and enhance overall cardiovascular health.

Related Sessions:

Committee Members

Professor
Lu Cai

University of Louisville School of Medicine, United States

Professor
Terry McCormack

Hull York Medical School, United Kingdom

Consultant Cardiologist
Abdul Majeed Salmasi

London Northwest University Healthcare NHS Trust, United Kingdom

Professor
Bernd Blobel

University of Regensburg, Germany

CVS 2026 Speakers

Professor
Emre Yalcinkaya

University of Health Sciences, Turkey

Professor
Guo Wei He

Tianjin University, China

Professor
Gausal Azam Khan

King Faisal University, Saudi Arabia

Researcher
Hai Tao Hou

Tianjin University, China

Tags

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top